JP2009540801A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540801A5
JP2009540801A5 JP2009515579A JP2009515579A JP2009540801A5 JP 2009540801 A5 JP2009540801 A5 JP 2009540801A5 JP 2009515579 A JP2009515579 A JP 2009515579A JP 2009515579 A JP2009515579 A JP 2009515579A JP 2009540801 A5 JP2009540801 A5 JP 2009540801A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
seq
fragment
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009515579A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070755 external-priority patent/WO2007149715A2/en
Publication of JP2009540801A publication Critical patent/JP2009540801A/ja
Publication of JP2009540801A5 publication Critical patent/JP2009540801A5/ja
Pending legal-status Critical Current

Links

JP2009515579A 2006-06-16 2007-06-08 トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質 Pending JP2009540801A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81424106P 2006-06-16 2006-06-16
PCT/US2007/070755 WO2007149715A2 (en) 2006-06-16 2007-06-08 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin

Publications (2)

Publication Number Publication Date
JP2009540801A JP2009540801A (ja) 2009-11-26
JP2009540801A5 true JP2009540801A5 (cg-RX-API-DMAC7.html) 2010-07-22

Family

ID=38834237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009515579A Pending JP2009540801A (ja) 2006-06-16 2007-06-08 トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質

Country Status (11)

Country Link
US (1) US8163876B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029167A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009540801A (cg-RX-API-DMAC7.html)
KR (1) KR20090027216A (cg-RX-API-DMAC7.html)
CN (1) CN101472607A (cg-RX-API-DMAC7.html)
AR (1) AR061484A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007261196A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0713671A2 (cg-RX-API-DMAC7.html)
CA (1) CA2654178A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007149715A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200808845B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2427641T3 (es) 2003-05-22 2013-10-31 Ibio, Inc. Molécula vehículo recombinante para la expresión, el suministro y la purificación de polipéptidos diana
KR101446025B1 (ko) 2005-08-03 2014-10-01 아이바이오, 인크. 면역글로불린의 생산을 위한 조성물 및 방법
CN101472607A (zh) * 2006-06-16 2009-07-01 美国陶氏益农公司 禽流感血凝素的新型dna序列、载体和蛋白质
EP2092059A4 (en) 2006-10-24 2012-03-28 Bogoch Samuel METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES
CA2689181A1 (en) 2007-05-30 2008-12-24 Samuel Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
WO2009009759A2 (en) 2007-07-11 2009-01-15 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
EP2300493A2 (en) * 2008-04-23 2011-03-30 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
JP5813505B2 (ja) * 2008-07-18 2015-11-17 メディカゴ インコーポレイテッド 新規インフルエンザウイルス免疫エピトープ
US20120034253A1 (en) * 2008-09-25 2012-02-09 Fraunhofer Usa, Inc. Influenza Vaccines, Antigens, Compositions, and Methods
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
AU2009344843A1 (en) * 2009-04-23 2011-11-10 Elenore S. Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
CN101693894B (zh) * 2009-10-15 2011-07-27 北京大学深圳研究生院 禽流感病毒h5n1假病毒及其制备方法与专用dna片段
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
IN2014CN03077A (cg-RX-API-DMAC7.html) * 2011-09-30 2015-07-03 Medicago Inc
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
RU2531235C2 (ru) 2013-02-15 2014-10-20 Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") Поливалентная вакцина против гриппа на основе гибридного белка
WO2015048129A1 (en) * 2013-09-24 2015-04-02 CHOI, Duk, Kyung Avian influenza virus polypeptides and methods of their use
EP3374390A1 (en) 2015-11-13 2018-09-19 Visterra, Inc. Compositions and methods for treating and preventing influenza
AU2017222564A1 (en) 2016-02-24 2018-09-06 Visterra, Inc. Formulations of antibody molecules to influenza virus
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
US11230593B2 (en) 2019-03-25 2022-01-25 Visterra, Inc. Compositions and methods for treating and preventing influenza
MX2023010985A (es) * 2021-03-18 2024-01-26 Calyxt Inc Matrices de celulas vegetales y procedimientos de las mismas.
EP4397318A4 (en) * 2021-08-30 2025-07-30 Japan Eco Science Co Ltd IMMUNOSTIMULATORY FORMULATION, AND COSMETIC, FOOD, FOOD ADDITIVE AND QUASI-MEDICAMENT PRODUCT CONTAINING SAID IMMUNOSTIMULATORY FORMULATION

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ543348A (en) 2003-05-05 2008-08-29 Thompson Boyce Plant Res Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
CA2568015C (en) * 2004-05-25 2013-08-27 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
KR20080109094A (ko) * 2006-04-21 2008-12-16 다우 아그로사이언시즈 엘엘씨 조류 인플루엔자 백신 및 이용방법
CN101472607A (zh) * 2006-06-16 2009-07-01 美国陶氏益农公司 禽流感血凝素的新型dna序列、载体和蛋白质

Similar Documents

Publication Publication Date Title
JP2009540801A5 (cg-RX-API-DMAC7.html)
JP6957580B2 (ja) 新規多価ナノ粒子に基づくワクチン
JP2009544333A5 (cg-RX-API-DMAC7.html)
JP2017503482A5 (cg-RX-API-DMAC7.html)
JP2007516696A5 (cg-RX-API-DMAC7.html)
JP2016503655A5 (cg-RX-API-DMAC7.html)
JP2014507146A5 (cg-RX-API-DMAC7.html)
Babin et al. Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
RU2011104999A (ru) Варианты гемагглютинина и нейрамидазы вируса гриппа
JP2019506175A5 (cg-RX-API-DMAC7.html)
CN101065145B (zh) 嵌合g蛋白基狂犬疫苗
CN101820903A (zh) 预防性和治疗性流感疫苗、抗原、组合物和方法
JP2012515557A5 (cg-RX-API-DMAC7.html)
HRP20100240T1 (hr) Polipeptidi za indukciju zaštitnog imunitetnog odgovora protiv staphylococcus aureus
KR101919002B1 (ko) 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도
JP2012516140A5 (cg-RX-API-DMAC7.html)
CN115427071A (zh) 包含ltb和病原性抗原的组合物及其用途
JP2008545393A5 (cg-RX-API-DMAC7.html)
JP2020509770A5 (cg-RX-API-DMAC7.html)
JP2020502075A5 (cg-RX-API-DMAC7.html)
RU2011137404A (ru) Варианты гемагглютинина и нейраминидазы гриппа
KR102647829B1 (ko) 삼량체를 형성하는 코로나-19 바이러스 (COVID-19, Coronavirus Disease 2019)의 재조합 스파이크 단백질 및 식물에서의 상기 재조합 스파이크 단백질의 대량 생산 방법과 이를 기반으로하는 백신조성물 제조 방법
JP2010514698A5 (cg-RX-API-DMAC7.html)
JP2009501012A5 (cg-RX-API-DMAC7.html)
TW200716166A (en) Lawsonia intracellularis immunological proteins